SCHEMBL1747339

SCHEMBL1747339

OCc1cccc(-c2c(F)cccc2F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.52
CNR2 P34972 2/20 0.47
DHODH Q02127 2/20 0.46
NPY5R Q15761 1/20 0.44
ACMSD Q8TDX5 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA7 P36544 1/20 0.44
CDK8 P49336 1/20 0.43
ENPP2 Q13822 1/20 0.42
CFTR P13569 1/20 0.42
MAP2K4 P45985 2/20 0.42
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
PRSS1 P07477 1/20 0.40
PRSS2 P07478 1/20 0.40
PRSS3 P35030 1/20 0.40
TTR P02766 1/20 0.40
FGFR1 P11362 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10984031 0.84 PRKCI (0.52) PRKCICNR2DHODHNPY5RACMSD
SCHEMBL4191589 0.80 PRKCI (0.72) PRKCICNR2ACMSDCHRNB4CHRNA3
SCHEMBL18297788 0.78 PRKCI (0.76) PRKCICNR2ACMSDCHRNB4CHRNA3
SCHEMBL12577793 0.78 PRKCI (0.46) PRKCICNR2DHODHNPY5RACMSD
SCHEMBL23450742 0.78 RAB9A (0.56) PRKCI
SCHEMBL9565253 0.78 TTR (0.46) HSD17B1HSD17B2TTR
SCHEMBL30484235 0.78 PRKCI (0.58) PRKCINPY5RACMSDCHRNB4CHRNA3
SCHEMBL26133200 0.78 PRKCI (0.58) PRKCINPY5RACMSDCHRNB4CHRNA3
SCHEMBL22937845 0.77 PRKCI (0.53) PRKCICNR2NPY5RACMSDCHRNB4
SCHEMBL23750141 0.76 PRKCI (0.67) PRKCICNR2DHODHACMSDCHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR PRKCI 3560/4885CNR2 429/4885DHODH 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.